Dynamic covalent poly(disulfide)-based cross-linked nanoaggregates,
termed nanonetworks (NNs), endowed with pH- and redox-responsive degradation
features have been fabricated for stable noncovalent encapsulation
and triggered cargo release in a controlled fashion. A bioderived
lipoic acid-based Gemini surfactant-like amphiphilic molecule was
synthesized for the preparation of nanoaggregates. It self-assembles
by a entropy-driven self-assembly process in aqueous milieu. To further
stabilize the self-assembled nanostructure, the core was cross-linked
by ring-opening disulfide exchange polymerization (RODEP) of 1,2-dithiolane
rings situated inside the core of the nanoaggregates. The cross-linked
nanoaggregates, i.e., nanonetwork, are found to be stable in the presence
of blood serum, and also, they maintain the self-assembled structure
even below the critical aggregation concentration (CAC) as probed
by dynamic light scattering (DLS) experiments. The nanonetwork showed
almost 50% reduction in guest leakage compared to that of the nanoaggregates
as shown by the release profile in the absence of stimuli, suggesting
high encapsulation stability as evidenced by the fluorescence resonance
energy transfer (FRET) experiment. The decross-linking of the nanonetwork
occurs in response to redox and pH stimuli due to disulfide reduction
and β-thioester hydrolysis, respectively, thus empowering disassembly-mediated
controlled cargo release up to ∼87% for 55 h of incubation.
The biological evaluation of the doxorubicin (DOX)-loaded nanonetwork
revealed environment-specific surface charge modulation-mediated cancer
cell-selective cellular uptake and cytotoxicity. The benign nature
of the nanonetwork toward normal cells makes the system very promising
in targeted drug delivery applications. Thus, the ease of synthesis,
nanonetwork fabrication reproducibility, robust stability, triggered
drug release in a controlled fashion, and cell-selective cytotoxicity
behavior, we believe, will make the system a potential candidate in
the development of robust materials for chemotherapeutic applications.